SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $39,995 | +35.7% | 40,000 | +33.3% | 0.02% | +40.0% |
Q4 2022 | $29,475 | +96.5% | 30,000 | +100.0% | 0.02% | +87.5% |
Q3 2022 | $15,000 | 0.0% | 15,000 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $15,000 | -48.3% | 15,000 | -50.0% | 0.01% | -38.5% |
Q3 2021 | $29,000 | -38.3% | 30,000 | -40.0% | 0.01% | -48.0% |
Q4 2020 | $47,000 | +2.2% | 50,000 | 0.0% | 0.02% | -10.7% |
Q3 2020 | $46,000 | +109.1% | 50,000 | +100.0% | 0.03% | +86.7% |
Q2 2020 | $22,000 | -50.0% | 25,000 | -54.5% | 0.02% | -55.9% |
Q1 2020 | $44,000 | – | 55,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |